Loading publications…
The last 5 uploaded publications
<i>CHL1</i> hypermethylation as a potential biomarker of poor prognosis in breast cancer
Esperanza Martín‐Sánchez, Saioa Mendaza, Ane Ulazia-Garmendia, Iñaki Monreal‐Santesteban, Idoia Blanco‐Luquin, Alicia Córdoba, Francisco Vicente-García, Noemí Pérez‐Janices, David Escors, Diego Megı́as, Paula López-Serra, Manel Esteller, José Juan Illarramendi, David Guerrero‐Setas (2017). <i>CHL1</i> hypermethylation as a potential biomarker of poor prognosis in breast cancer. , 8(9), DOI: https://doi.org/10.18632/oncotarget.15004.
Article73 days ago<i>CHL1</i> hypermethylation as a potential biomarker of poor prognosis in breast cancer
Esperanza Martín‐Sánchez, Saioa Mendaza, Ane Ulazia-Garmendia, Iñaki Monreal‐Santesteban, Idoia Blanco‐Luquin, Alicia Córdoba, Francisco Vicente-García, Noemí Pérez‐Janices, David Escors, Diego Megı́as, Paula López-Serra, Manel Esteller, José Juan Illarramendi, David Guerrero‐Setas (2017). <i>CHL1</i> hypermethylation as a potential biomarker of poor prognosis in breast cancer. , 8(9), DOI: https://doi.org/10.18632/oncotarget.15004.
Article73 days ago<i>CHL1</i> hypermethylation as a potential biomarker of poor prognosis in breast cancer
Esperanza Martín‐Sánchez, Saioa Mendaza, Ane Ulazia-Garmendia, Iñaki Monreal‐Santesteban, Idoia Blanco‐Luquin, Alicia Córdoba, Francisco Vicente-García, Noemí Pérez‐Janices, David Escors, Diego Megı́as, Paula López-Serra, Manel Esteller, José Juan Illarramendi, David Guerrero‐Setas (2017). <i>CHL1</i> hypermethylation as a potential biomarker of poor prognosis in breast cancer. , 8(9), DOI: https://doi.org/10.18632/oncotarget.15004.
Article73 days ago